Metcela Inc. | Revolutionizing the Way We Treat Heart Failure > NEWS > PRESS RELEASE > Metcela eligible to receive up to $7 Million (1 Billion JPY) AMED Grant for Promoting the Development of Regenerative Medicine Product Using Cardiac Stem Cells > JRM-001scheme_E 2022.11.15 JRM-001scheme_E | Metcela Inc. | Revolutionizing the Way We Treat Heart Failure